• PIK3CA mutation-associated gene expression signature correlates with deactivation of the PI3K pathway and predicts benefit to endocrine therapy in high-risk ER+ (luminal B) breast cancers (BC)
Auteur:Sotiriou, Christos; Loi, Sherene; Haibe-Kains, Benjamin; Lallemand, Françoise; Pusztai, Lajos; Bardelli, A.; Bedard, Philippe L; Gillet, Cheryl; Ellis, Paul; Phillips, W.A.; Piccart-Gebhart, Martine; McArthur, Grant A
Informations sur la publication:AACR Annual meeting(April 2009: Denver, Co, USA), Proc Am Assoc Cancer Res.
Statut de publication:Publié, 2009-04
Sujet CREF:Cancérologie
Médecine pathologie humaine